The mitigation of TRX1 inhibition-induced ROS by AR depletion, and the direct oxidant-mediated increase in AR expression (in both androgen-replete and AD conditions) suggests the existence of a regulatory loop between AR and cellular ROS whereby AR both produces and is responsive to ROS levels. This evidence concerns the gene AR and Alzheimer disease.